Clinical Trial Update: SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SSRI administration to reduce acute stress disorder symptoms and prevent depression and post-traumatic stress disorder in physical tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Post-traumatic Stress Disorder
• Stress Disorder

Drugs mentioned

• SSRI (selective serotonin reuptake inhibitor) (selective serotonin reuptake inhibitor)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Anxiety Disorder | Phase 3 | Status: TERMINATED